Immunosuppressive drugs and the foetus

Area of Science:

• Immunology
• Transplant Medicine
• Genetics

Background:

• Investigating the effects of maternal immunosuppressive therapy on infant health.
• Focusing on infants born after maternal renal transplantation.
• Examining the impact of azathioprine and prednisone exposure in utero.

Observation:

• Two infants were monitored for over two years.
• Initial observations included lower-than-normal lymphocyte counts and cortisol levels.
• Presence of chromosomal aberrations in infant lymphocytes at birth was noted.

Findings:

• Maternal immunosuppressants (azathioprine, prednisone) did not lead to persistent adverse effects.
• Chromosomal aberrations, mirroring maternal findings, were transient in infants.
• Lymphocyte and cortisol levels normalized over the follow-up period.

Implications:

• Suggests potential for fetal adaptation to maternal immunosuppressive drugs.
• Highlights the importance of long-term monitoring of infants post-transplant pregnancies.
• Provides insights into the safety profile of certain immunosuppressants in pregnancy.